Esomeprazole Market: Global Opportunity Analysis and Industry Forecast, 2022-2029

Esomeprazole is a compound isomer of omeprazole that is administered in the magnesium salt form. It is sold under the name of Nexium and used for the treatment of esophagitis, gastroesophageal reflux disease, peptic ulcer, reduces stomach acid and Zollinger–Ellison syndrome. The route of administration of esomeprazole is oral or injected directly into vein. Further, it has many side effects such as headache, constipation, dry mouth, abdominal pain, and some serious side effects are angioedema, pneumonia and Clostridium infection. Esomeprazole is used for a safe pregnancy and also used post-pregnancy by females during breastfeeding. It works by obstructing H+/K+-ATPase in the cells of stomach. It mainly works for overall benefits in esophageal and symptoms relief. 

Esomeprazole capsule is coated with barrier polymer due to mortification of the drug in acidic conditions of the stomach and this is done by using the multiple-unit pellet system. Due to this someprazole tablets are also known as "multiple-unit pellet system" (MUPS). When the capsule is treated with aqueous solution, then water enters the capsule by osmosis and the contents get absorbed due to breakage of shell.

COVID-19 Scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs.

Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Esomeprazole is used in the treatment of the symptoms of heartburn and disorders which involves excessive stomach acids, increasing usage of esomeprazole for the treatment of diseases would drive the growth. Low treatment cost, easily availability and these drugs are sold without any prescription and decreases the overall cost. Due to these reasons, drugs have the potential to increase their growth in the
esomeprazole market.

Increase in the adoption of drug delivery systems and successful launch of new products is driving the esomeprazole market growth. The major factor in the esomeprazole market growth is increase in the intensity of GERD (Gastroesophageal reflux disease), which is a dangerous and highly risky disorder. It is majorly found in the middle-aged and older people. There are many minor side effects of this drug like nausea, headaches, dry mouth, diarrhea and major side effects like kidney disease and dementia, which are restraining factors for the growth of the esomeprazole market.

Key benefits of the report:

• This study presents the analytical depiction of the esomeprazole market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global esomeprazole market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global esomeprazole market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the esomeprazole market.
• The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Esomeprazole Market research report:

• What are the leading market players active in the Esomeprazole Market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What can be the challenges for global Esomeprazole Market in future?
• What are the projections for the future that would help in taking further strategic steps?

 Key Market Segments

 
Key Market Players

• Teva
• Blaskov
• Astra Zeneca AB
• Garmish Pharmaceutical
• Mepha
• CQ Lummy
• Stada
• Actavis
• Mylan
• Sandoz
• Sanofi
• Saval Pharmaceutical
• KernPharm